Putney, Inc. Launches Veterinary Advisory Board
Date: February 17, 2009
Putney, Inc. Launches Veterinary Advisory Board; Prestigious team of experts provide strategic advice on product development
Portland, Maine—February 17, 2009—Putney, Inc., a pharmaceutical company focused on the development of drugs for pets, has established a Veterinary Advisory Board to provide veterinary expertise in targeting and evaluating clinical safety and efficacy of product candidates. Putney is focused on new drug candidates to meet unmet veterinary needs for chronic and frequently diagnosed indications, building on the company's pipeline of prescription generic drugs for dogs and cats. Veterinary Advisory Board members are Dr. Pete Bill, director of the Veterinary Technology Program at Purdue University; Dr. Gary Block of Ocean State Veterinary Specialists; Dr. Whadzen Carrasquillo of Jones Bridge Animal Hospital; Dr. Hugh Lewis, former Dean of the School of Veterinary Medicine at Purdue University; and Dr. Mark Papich, Professor of Clinical Pharmacology in the College of Veterinary Medicine at North Carolina State University.
The Veterinary Advisory Board will provide strategic input into the identification and evaluation of products in Putney's development portfolio. "We are privileged to have the breadth of clinical experience and depth of expertise on our Veterinary Advisory Board to help us broaden our pipeline to assist companion animal veterinarians in treating pet patients. Their insights will help us target the right specialty pharmaceuticals for development that solve problems in dosing, compliance, efficacy, palatability and affordability of drugs for pets," says Jean Hoffman, founder and CEO of Putney.
Board members' areas of expertise cover a wide range of business and academic sectors including both large and small practices, specialty veterinary hospitals, large, national pet health centers, and university veterinary hospital settings.
Putney, Inc. is a pharmaceutical company focused on the development of drugs for pets. The company's goal is to offer high quality prescribing options which allow veterinarians to meet pet owner demands for improved palatability, administration and pricing, and increase pet owner compliance with the veterinarian's prescription. The company is expanding its broad pipeline of prescription drugs for cats and dogs with new, specialty pharmaceuticals. Learn more at www.putneyvet.com.
Contact: Christina Perkins, Vice President, Marketing & Communications
207-553-4430, christina.perkins@putneyvet.com